<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sun R</submitter><funding>State Key Laboratory of Radiation Medicine and Protection</funding><funding>National Natural Science Foundation of China</funding><funding>Major Research Plan</funding><funding>Natural Science Foundation of Jiangsu Province</funding><pagination>2369-2378</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9977396</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(9)</volume><pubmed_abstract>Spatiotemporally manipulating the &lt;i>in situ&lt;/i> immobilization of theranostic agents within cancer cells to improve their bioavailability is highly significant yet challenging in tumor diagnosis and treatment. Herein, as a proof-of concept, we for the first time report a tumor-targetable near-infrared (NIR) probe DACF with photoaffinity crosslinking characteristics for enhanced tumor imaging and therapeutic applications. This probe possesses great tumor-targeting capability, intensive NIR/photoacoustic (PA) signals, and a predominant photothermal effect, allowing for sensitive imaging and effective photothermal therapy (PTT) of tumors. Most notably, upon 405 nm laser illumination, DACF could be covalently immobilized within tumor cells through a photocrosslinking reaction between photolab</pubmed_abstract><journal>Chemical science</journal><pubmed_title>A tumor-targetable NIR probe with photoaffinity crosslinking characteristics for enhanced imaging-guided cancer phototherapy.</pubmed_title><pmcid>PMC9977396</pmcid><funding_grant_id>GZK1202132</funding_grant_id><funding_grant_id>22077092</funding_grant_id><funding_grant_id>91959123</funding_grant_id><funding_grant_id>GZK1202140</funding_grant_id><funding_grant_id>81902913</funding_grant_id><funding_grant_id>BK20190821</funding_grant_id><funding_grant_id>GZK1202017</funding_grant_id><pubmed_authors>Zhao M</pubmed_authors><pubmed_authors>Wang A</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Sun R</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Gao Y</pubmed_authors><pubmed_authors>Cheng X</pubmed_authors><pubmed_authors>Shi H</pubmed_authors></additional><is_claimable>false</is_claimable><name>A tumor-targetable NIR probe with photoaffinity crosslinking characteristics for enhanced imaging-guided cancer phototherapy.</name><description>Spatiotemporally manipulating the &lt;i>in situ&lt;/i> immobilization of theranostic agents within cancer cells to improve their bioavailability is highly significant yet challenging in tumor diagnosis and treatment. Herein, as a proof-of concept, we for the first time report a tumor-targetable near-infrared (NIR) probe DACF with photoaffinity crosslinking characteristics for enhanced tumor imaging and therapeutic applications. This probe possesses great tumor-targeting capability, intensive NIR/photoacoustic (PA) signals, and a predominant photothermal effect, allowing for sensitive imaging and effective photothermal therapy (PTT) of tumors. Most notably, upon 405 nm laser illumination, DACF could be covalently immobilized within tumor cells through a photocrosslinking reaction between photolab</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-04T20:18:14.518Z</modification><creation>2025-02-19T02:21:41.229Z</creation></dates><accession>S-EPMC9977396</accession><cross_references><pubmed>36873836</pubmed><doi>10.1039/d2sc06413h</doi></cross_references></HashMap>